Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms
The present disclosure provides improved methods for bead beating and a bead beating system useful therefor. The present disclosure further provides methods of using the bead beating system to extract nucleic acids from cells containing the nucleic acids.
1. A method for producing and recovering a lysate from cells contained in blood containing an anticoagulant, and analyzing one or more nucleic acids from the lysate, comprising:
a) agitating the blood within a bead beating system in the absence of any additive other than the anticoagulant, under conditions sufficient to lyse both a fungal pathogen and a bacterial pathogen and provide a lysate suitable for PCR amplification of DNA from the fungal pathogen, when present, and the bacterial pathogen, when present, said bead beating system comprising (i) a sample tube or blood collection tube and (ii) beads;
b) recovering the lysate from the sample tube or blood collection tube; and
c) analyzing one or more nucleic acids from the lysate, wherein the analyzing comprises PCR to amplify DNA from the fungal pathogen, when present, and DNA from the bacterial pathogen, when present.
2. The method of claim 1 , wherein the beads are adapted to lyse yeast or filamentous fungi.
3. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Candida albicans and (ii) provide a lysate suitable for PCR amplification of DNA from Candida albicans , when the Candida albicans is present.
4. The method of claim 3 , which comprises agitating the blood under conditions sufficient to (i) lyse Staphylococcus aureus and (ii) provide a lysate suitable for PCR amplification of DNA from Staphylococcus aureus , when the Staphylococcus aureus is present.
5. The method of claim 4 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.
6. The method of claim 3 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.
7. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Staphylococcus aureus and (ii) provide a lysate suitable for PCR amplification of DNA from Staphylococcus aureus , when the Staphylococcus aureus is present.
8. The method of claim 7 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.
9. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.
10. The method of claim 1 , wherein the agitating comprises subjecting the bead beating system to an oscillating motion.
11. The method of claim 1 , wherein the agitating is performed with a vortexer or a homogenizer.
12. The method of claim 1 , wherein the agitating comprises subjecting the bead beating system to 2000 or more oscillations per minute.
13. The method of claim 1 , wherein the agitating is performed for 25-60 seconds.
14. The method of claim 1 , wherein the agitating is performed for 1-2 minutes.
15. The method of claim 1 , wherein the anticoagulant is EDTA, citrate, oxalate or heparin.
16. The method of claim 1 , wherein the cells comprise one or more pathogens.
17. The method of claim 16 , wherein the cells comprise one or more bacterial pathogens, viral pathogens, fungal pathogens, or a combination thereof.
18. The method of claim 17 , wherein the cells comprise one or more fungal pathogens.
19. The method of claim 18 , wherein the one or more fungal pathogens comprise Candida albicans.
20. The method of claim 17 , wherein the cells comprise one or more bacterial pathogens.
21. The method of claim 20 , wherein the one or more bacterial pathogens comprise Staphylococcus aureus.
22. The method of claim 20 , wherein the one or more bacterial pathogens comprise Escherichia coli.
23. The method of claim 1 , wherein the blood comprises cells from multiple species.
24. The method of claim 1 , further comprising purifying one or more nucleic acids from the lysate prior to PCR.
25. The method of claim 1 , further comprising using a microarray to analyze the one or more nucleic acids or sequencing the one or more nucleic acids following PCR.